Amgad Gerges
About
MSc in medicinal chemistry, a BSc (Hons) in biomedical science, a BSc in chemistry, a foundation degree in Christian theology and a Fellowship of Higher Education. I have been working in the NHS since 1994, starting as an Honorary Research Assistant at King's College Hospital. Moving forward from 1997, I began as a Trinee BMS and have spent nearly 30 years in the blood science laboratory, alternating between biochemistry, haematology, and blood transfusion. Currently, I am a senior lecturer in Biomedical Science and Medicinal Chemistry, and I also serve as a consultant advisor for staff training and development in a teaching hospital in London. I am also an external examiner in higher education and an assessor for the IBMS. Research interests In 2019, I started working on the discovery of a drug for the treatment of neuroblastoma stage 4 (NSB4) Bibliography Gerges, A.; Canning, U. High-Risk Neuroblastoma Stage 4 (NBS4): Developing a Medicinal Chemistry Multi-Target Drug Approach. Molecules 2025, 30, 2211. https://doi.org/10.3390/molecules30102211 Gerges A, Canning U. High-risk neuroblastoma stage 4 (NBS4): multi-target inhibitors for c-Src kinases (Csk) and retinoic acid (RA) signalling pathways. Explor Drug Sci. 2025;3:1008109. https://doi.org/10.37349/eds.2025.1008109 Gerges, A. and Canning, U. (2024). "Neuroblastoma and its Targets Therapies: A Medicinal Chemistry Review." CHEMMEDCHEM: https://doi.org/10.1002/cmdc.202300535 Butterworth RJ, Wassif WS, Sherwood RA, Gerges A, Bath PMW, Peters TJ. Serum neurone specific enolase and carnosinase in acute stroke: an enzyme test for predicting outcome in stroke? Stroke 1996; 27:2064-2068. WS Wassif, F Li, P Pitt, D Sherman, A Gerges, C MacKintosh, M Buxton-Thomas, C Moniz, T J Peters; Biochemical Markers of Bone Turnover and Dual Energy X-Ray Absorptiometry in Alcohol Misusers. Clin Sci (Lond) 1 July 1995; 89 (s33): 9P. doi: https://doi.org/10.1042/cs089009P Butterworth RJ, Wassif WS, Gerges A, Sherwood RA, Peters TJ, Bath PMW. Serum carnosinase activity is reduced in acute stroke. Cerebrovasc Dis 1995; 5:246. (Abstract) Wassif WS, Butterworth RJ, Gerges A, Bath PMW, Sherwood RA, Peters TJ. Serum carnosinase activity following cerebral infarction or haemorrhage. Proc ACB National Meeting, May 1995; C49: 154. (Abstract) Professional Activity State-registered biomedical scientist with the Health and Care Professions Council (HCPC). Member of the Institute of Biomedical Scientists (IBMS) and an external Examiner/Assessor for the Institute of Biomedical Scientists. Member of the British Society of Haematology and a member of the General Haematology Sounding Board Member of the UK Board of Healthcare Chaplaincy.